logo
Plus   Neg
Share
Email

Abbott Begins Trial To Evaluate Transcatheter Tricuspid Valve Repair

Abbott (ABT) has launched TRILUMINATE pivotal trial to evaluate TriClip transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation. The study is a multi-center global study of approximately 700 patients. Patients will be randomized to receive either the TriClip device or medical therapy and followed for a total of five years.

Abbott's TriClip tricuspid valve repair system is built on the company's MitraClip technology. The TriClip device was accepted for national reimbursement consideration through a process known as "Parallel Review" by the FDA.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Justice has reached a settlement agreement with a Texas-based Taco Bell franchise owner for immigration-related discrimination against certain employees. The settlement resolves the DOJ's investigation into whether MUY Brands LLC, and a related management company, MUY Consulting Inc., violated the Immigration and Nationality Act. Starbucks is gearing up for the upcoming holiday season by introducing its 2019 holiday flavors in U.S. grocery stores. The launch of the coffee giant's holiday line-up this year includes returning holiday favorites as well as a new item. Customers can now take home products that are making a comeback such as Starbucks Holiday Blend K-Cup and Ground Coffee, Peppermint Mocha Flavored Ground Coffee, Peekay International issued a recall of 7 ounce and 14 ounce packs containing Keshav Dry Apricot food treats as they contain undeclared allergens such as sulfites, according to a statement published by The U.S. Food and Drug Administration. Consumption of the product by those allergic or having severe sensitivity to sulfites could run the risk of serious or life-threatening allergic reactions.
Follow RTT
>